-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
1/43
Adjusted EPS
Company 2002 2001 2000 1999 1998
Abbott Lab I Ltd 6.72 10.78 24.96 17.68 2.28
Ajanta Pharma Ltd 1.51 5.96 21.02 23.54 21.22
Aurobindo Pharma Ltd 25.22 32.93 73.41 52.63 50.55
Cadila Healthcare Ltd 10.70 10.56 6.65 13.95 13.35
Cipla Ltd 37.87 28.83 21.91 57.10 52.59
Dr Reddys Lab Ltd 60.21 45.11 22.84 19.26 22.26
Duphar Int Ltd 20.98 15.69 45.75 32.39 11.88
German Remedies Ltd 29.68 39.59 39.07 31.91 24.90Glaxo India Ltd 15.58 11.57 9.22 11.13 8.99
Lupin Lab Ltd 9.88 7.18 10.91 9.06 17.15
Max India Ltd 6.44 6.75 32.11 153.97 (5.81)
Morepen Lab Ltd 4.24 7.56 25.40 17.37 13.84
Nicholas Piramal I Ltd 17.45 19.81 15.54 15.76 24.35
Novartis I Ltd 15.02 11.17 32.23 23.81 15.64
Orchid Chem & Pharma 2.25 13.01 8.35 18.81 19.66
Pfizer India 20.90 17.59 30.97 19.46 17.61
Smithkline Bec Pharma 10.44 8.81 11.60 22.88 13.19
Sun Pharma Ind Ltd 36.43 27.77 50.47 37.10 36.36
Torrent Pharma 24.08 17.16 16.76 15.33 18.59
Zandu Pharma 167.57 126.65 52.63 135.31 121.62
Definition
Formula
(20.00)
-
20.00
40.00
60.00
80.00
100.00
120.00
140.00
160.00
180.00
1998
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
2/43
Comment:-
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
3/43
EPS is a small variation of return on equity capital ratio and is calculated by dividing the net
profit after taxes and preference dividend by the total number of equity shares.
ADJUSTED EPS RATIO = EBIT ADJUSTMENT / NO. OF EQUITY SHARES
1999 2000 2001 2002
Abbott Lab I Ltd
Ajanta Pharma Ltd
Aurobindo Pharma Ltd
Cadila Healthcare Ltd
Cipla Ltd
Dr Reddys Lab Ltd
Duphar Int LtdGerman Remedies Ltd
Glaxo India Ltd
Lupin Lab Ltd
Max India Ltd
Morepen Lab LtdNicholas Piramal I Ltd
Novartis I Ltd
Orchid Chem & Pharma
Pfizer IndiaSmithkline Bec Pharma
Sun Pharma Ind Ltd
Torrent Pharma
Zandu Pharma
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
4/43
From the case, we can analyze that, Ajanta Pharmaceuticals Ltd has been studiedly declining
from the year 1998 to 2002 that is from 21.22 to 1.51 by which we can the company is losing
its business and in future eventually may undergo to the bankruptcy.
On the other side, the company Dr. Reddy's Laboratories show a steady growth from year
1998 to 2002 approximately a growth by 170.49% which is better than other pharma
companies. Apart from Dr. Reddy's Laboratories, the companies like Duphar Interfran Ltd,
German Remedies Ltd, Glaxo India Ltd, Pfizer Ltd, Torrent Pharmaceuticals Ltd and Zandu
Pharmaceuticals Works Ltd also shows a steady growth in the Industry.Zandu Pharmaceuticals Works Ltd shows a higher Earning per share for all the five years
indicating a good measure of profitability and shows that the earning power of the company
has increased.
It can also be analyze that, the pharmacy company like Max India Ltd shows a highest
negative slowdown in the industry indicating a negativity of around 210% form the year 1998
to 2002 which also includes other companies like Orchid Chemicals and Pharmaceuticals,
Morepen Laboratories Ltd and Aurobindo Pharma Ltd.
The company like Sun Pharmaceutical Industries Ltd shows a consistency in the Earning Per
Share ratio right from year 1998 to 2002. Max India Ltd shows a great negativity but has
improved his performance from year 1998 to 2002 showing a positive sign.
Hence, a company giving high Growth fund can be Dr. Reddy's Laboratories and ZanduPharmaceuticals Works Ltd where as a Consistent return fund can be considered as Sun
Pharmaceutical Industries Ltd and Novartis India Ltd.
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
5/43
Dividend Per Share
Company 2002 2001 2000 1999 1998
Abbott Lab I Ltd - 2.00 3.00 1.25 -
Ajanta Pharma Ltd 1.50 1.50 1.50 1.50 1.30
Aurobindo Pharma Ltd 3.00 3.00 5.00 5.00 5.00
Cadila Healthcare Ltd 3.50 3.00 3.00 - 4.00Cipla Ltd 7.00 4.50 5.50 7.50 5.50
Dr Reddys Lab Ltd 7.50 4.00 3.00 3.00 3.00
Duphar Int Ltd 6.00 2.50 5.00 5.00 2.50
German Remedies Ltd 8.00 7.00 9.00 7.00 4.50
Glaxo India Ltd 5.50 5.00 6.00 5.00 4.00
Lupin Lab Ltd 2.50 2.50 2.50 2.50 5.00
Max India Ltd - 3.50 28.75 104.50 2.00
Morepen Lab Ltd 3.00 3.50 3.50 3.00 2.50
Nicholas Piramal I Ltd 8.50 7.00 6.50 5.50 10.00
Novartis I Ltd 7.50 7.50 15.00 8.50 4.00Orchid Chem & Pharma 4.00 4.00 4.00 4.00 4.00
Pfizer India 5.00 4.00 5.00 4.00 3.00
Smithkline Bec Pharma 4.00 3.00 3.00 5.00 3.50
Sun Pharma Ind Ltd 5.00 5.00 10.00 8.00 6.00
Torrent Pharma 8.00 7.50 - 6.00 5.00
Zandu Pharma 40.00 37.00 37.00 37.00 35.00
Definition
Formula
Comment
-2.004.006.008.00
10.0012.0014.0016.00
18.0020.0022.0024.0026.0028.0030.0032.0034.0036.0038.0040.0042.0044.0046.0048.0050.00
52.0054.0056.0058.0060.0062.0064.0066.0068.0070.0072.0074.0076.0078.0080.0082.0084.00
86.0088.0090.0092.0094.0096.0098.00
100.00
1
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
6/43
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
7/43
v en s are a orm o pro s r u on o e s are o er. av ng a grow ng
dividend per share can be a sign that the company's management believes that the
Dividend Per Share = Dividend paid to ordinary shareholders / Number of equity sha
From the data given from the case, we can analyze that the company including Zandu
Pharmaceuticals Works Ltd shows the highest dividend per share ratio for the years
apart from the year 1999. Also, the company Nicholas Piramal India Ltd shows a
stable ratio throughout all the five years. Even the company like Novartis India Ltd
998 1999 2000 2001
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
8/43
from 2.00 to 104.50 but on the other side it shows a highest fall right after 1999 to
2002 that is from 104.50 to 0.00 which indicates that the company does not have a
good sign of growth and cannot be sustain no longer in the pharmacy industry,
whereas the company like Zandu Pharmaceuticals Works Ltd provides the highest
dividend to its shareholders. Apart from the company like Zandu Pharmaceuticals
Works Ltd , a company like Lupin Laboratories and Cadila Healthcare Ltd provides aHence, a company showing a positive sign enables that the company earns a healthy
return on its sales and provides its profit sharing in the form of if dividend to its
However, a company giving high Growth fund can be Zandu Pharmaceuticals Works
Ltd where as a Consistent return fund can be considered as Nicholas Piramal India
Ltd and Novartis India Ltd.
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
9/43
es Number of equity.
2002
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
10/43
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
11/43
Abbott Lab I LtdAjanta Pharma Ltd
Aurobindo Pharma Ltd
Cadila Healthcare Ltd
Cipla Ltd
Dr Reddys Lab Ltd
Duphar Int Ltd
German Remedies Ltd
Glaxo India Ltd
Lupin Lab Ltd
Max India Ltd
Morepen Lab Ltd
Nicholas Piramal I Ltd
Novartis I Ltd
Orchid Chem & Pharma
Pfizer India
Smithkline Bec Pharma
Sun Pharma Ind Ltd
Torrent Pharma
Zandu Pharma
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
12/43
Book Value
Company 2002 2001 2000 1999 1998
Abbott Lab I Ltd 71.35 72.09 128.04 25.34 14.13
Ajanta Pharma Ltd 141.55 142.97 113.16 98.94 79.19
Aurobindo Pharma Ltd 174.51 138.19 210.69 122.15 145.94
Cadila Healthcare Ltd 92.63 90.91 82.38 37.14 42.24
Cipla Ltd 146.65 119.02 94.11 225.61 176.40Dr Reddys Lab Ltd 190.55 145.19 143.95 128.68 113.96
Duphar Int Ltd 257.18 228.38 254.87 216.24 206.65
German Remedies Ltd 181.49 171.25 138.91 109.76 84.41
Glaxo India Ltd 75.27 65.99 60.32 54.14 45.14
Lupin Lab Ltd 79.66 73.77 72.87 83.15 79.30
Max India Ltd 219.34 224.12 450.93 163.16 124.69
Morepen Lab Ltd 42.98 47.79 205.49 112.72 95.76
Nicholas Piramal I Ltd 65.93 117.67 106.31 111.49 104.01
Novartis I Ltd 65.27 52.34 102.80 86.99 72.99
Orchid Chem & Pharma 107.03 135.16 129.25 95.48 81.32Pfizer India 72.47 55.71 89.37 64.19 60.84
Smithkline Bec Pharma 60.02 54.14 49.67 84.67 67.83
Sun Pharma Ind Ltd 114.51 92.52 204.35 168.04 143.10
Torrent Pharma 108.41 105.27 93.02 82.72 74.82
Zandu Pharma 886.76 779.81 688.04 631.95 536.90
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
13/43
Definition
Formula
Comments
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
14/43
The value at which an asset is carried on a balance sheet.
Total Assets less Intangible Assets / No. of Shares Outstanding
From the given data and a graph arrived, we can clearly indicates that the Zandu
Pharma Shows a very high growth rate from the year 1998 to 2002. There has been
significant increase of approximately 65%. Along with Zandu Pharma Dr. Reddy Lab
Ltd also shows a very significant growth of around 67%. Hence both the pharma
On the other side, it can be analysed that the company like Duphar Interfran Ltd,
Ajanta Pharmaceuticals, Lupin Laboratories Ltd shows a high amount of stableThe company showing low book value under its Balance Sheet portfolio analysed and
cannot be stabilized in the market, the company which includes Sun Pharma
Industries Ltd, Smithkline Beecham Pharmaceuticals , Morepen Laboratories,
However, a company giving high Growth fund can be Zandu Pharmaceuticals Works
Ltd , Dr. Reddy Lab Ltd and Torrent Pharmaceuticals Ltd where as a Consistent
4.0034.0064.00
94.00
124.00154.00
184.00214.00
244.00274.00
304.00334.00
364.00394.00
424.00454.00
484.00514.00
544.00574.00
604.00
634.00664.00
694.00724.00
754.00784.00
814.00844.00
874.00
1998 1999 2000 2001
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
15/43
2002
Abbott Lab I Ltd
Ajanta Pharma Ltd
Aurobindo Pharma Ltd
Cadila Healthcare Ltd
Cipla Ltd
Dr Reddys Lab Ltd
Duphar Int Ltd
German Remedies Ltd
Glaxo India Ltd
Lupin Lab Ltd
Max India Ltd
Morepen Lab Ltd
Nicholas Piramal I Ltd
Novartis I LtdOrchid Chem & Pharma
Pfizer India
Smithkline Bec Pharma
Sun Pharma Ind Ltd
Torrent Pharma
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
16/43
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
17/43
Zandu
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
18/43
Duphar Abbott
Cadila Cipla
Glaxo Smithklin
Torrent Orchid
Morepen
Novartis
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
19/43
Return on Net Worth
Company 2002 2001 2000 1999 1998
Abbott Lab I Ltd 8.59 8.58 5.23 5.88 (3.56)
Ajanta Pharma Ltd 1.07 3.59 16.52 22.20 26.65
Aurobindo Pharma Ltd 18.99 24.65 34.88 43.06 34.47
Cadila Healthcare Ltd 11.84 12.02 8.10 37.45 26.96
Cipla Ltd 26.73 25.08 23.57 25.48 28.91Dr Reddys Lab Ltd 31.52 31.49 15.82 15.18 16.18
Duphar Int Ltd 12.33 0.95 17.51 14.96 6.29
German Remedies Ltd 16.64 23.39 28.29 30.08 29.91
Glaxo India Ltd 13.43 17.88 21.37 20.74 20.62
Lupin Lab Ltd 12.13 10.97 15.08 12.04 18.88
Max India Ltd 1.86 0.99 7.15 93.78 6.95
Morepen Lab Ltd 12.60 15.76 12.25 17.28 14.44
Nicholas Piramal I Ltd 36.90 17.97 15.36 14.67 19.62
Novartis I Ltd 31.30 24.98 31.57 26.93 16.48
Orchid Chem & Pharma 2.10 9.63 10.66 21.45 24.16Pfizer India 27.95 28.74 29.52 16.72 19.32
Smithkline Bec Pharma 17.26 15.52 22.77 26.66 19.38
Sun Pharma Ind Ltd 31.72 30.29 27.09 22.06 25.77
Torrent Pharma 22.43 25.73 10.77 19.05 24.48
Zandu Pharma 18.16 16.90 7.88 21.92 23.76
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
20/43
Definition
Formula
Comments
(4.00)
16.00
36.00
56.00
76.00
96.00
116.00
136.00
1998
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
21/43
Return on networth is used in the finance as a measure of companies profitabilityIt also reveals that how much profit a company can generates with money that the
companies shareholder has invested.
Return on Networth = Net Income / Shareholder's Equity * 100
From the given data, we can analysed that every company shows ups and downs in
all the five years, here it means companies are being volatile in the market.
But a Company like Abbott laboratories India Ltd which shows a negative return in
the year 1998 but therefter it shows a steady growth in the coming four years wherein
Companies like Pfizer Ltd , Nicholas Piramal India Ltd, Novartis India Ltd and Dr.
Reddy Laboratories Ltd shows a high growth in the pharmacy industries though the
above comapanies where being volatile in the market but there has been significant
The companies like Ajanta Pharmaceuticals Ltd , Aurobindo Pharma Ltd and Orchid
Chemicals and Pharmaceuticals turns up to low return provider to its shareholders.
It can also be analysed that the company like Sun Phamaceutical Industries Ltd and
Cipla Ltd shows a consistant return to its shareholders as per its market share.
1999 2000 2001 2002
Abbott Lab I Ltd
Ajanta Pharma Ltd
Aurobindo Pharma Ltd
Cadila Healthcare Ltd
Cipla Ltd
Dr Reddys Lab Ltd
Duphar Int Ltd
German Remedies Ltd
Glaxo India Ltd
Lupin Lab Ltd
Max India Ltd
Morepen Lab Ltd
Nicholas Piramal I Ltd
Novartis I Ltd
Orchid Chem & Pharma
Pfizer India
Smithkline Bec Pharma
Sun Pharma Ind Ltd
Torrent Pharma
Zandu Pharma
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
22/43
Total Debt/Equity
Company 2002 2001 2000 1999 1998
Abbott Lab I Ltd - 0.04 0.11 1.71 1.68
Ajanta Pharma Ltd 0.36 0.25 0.57 0.79 0.82
Aurobindo Pharma Ltd 0.99 0.81 0.71 1.03 1.02
Cadila Healthcare Ltd 0.48 0.10 0.45 1.65 1.21
Cipla Ltd 0.03 0.03 0.03 0.07 0.05Dr Reddys Lab Ltd 0.01 0.67 0.40 0.28 0.17
Duphar Int Ltd 0.01 0.06 0.06 0.09 0.05
German Remedies Ltd - 0.01 0.04 0.15 0.16
Glaxo India Ltd 0.01 0.08 0.05 0.06 0.19
Lupin Lab Ltd 1.78 2.05 1.92 2.07 2.04
Max India Ltd 0.36 0.24 0.17 0.24 0.84
Morepen Lab Ltd 1.58 1.12 0.99 1.34 1.01
Nicholas Piramal I Ltd 1.18 0.26 0.29 0.37 1.34
Novartis I Ltd 0.05 0.56 0.04 0.09 0.11
Orchid Chem & Pharma 1.44 0.83 0.91 1.84 1.31Pfizer India - - - 0.01 0.26
Smithkline Bec Pharma - - - - -
Sun Pharma Ind Ltd 0.02 0.15 0.30 0.44 0.25
Torrent Pharma 0.09 0.35 0.48 1.71 1.62
Zandu Pharma 0.27 0.81 0.90 1.15 1.68
Definition
Formula
Comments
-
0.50
1.00
1.50
2.00
2.50
1998
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
23/43
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
24/43
The debt-to-equity ratio (D/E) is a financial ratio indicating the relative proportion of
shareholders' equity and debt used to finance a company's assets.
Debt to Equity Ratio = Debt (Liabilities) / Equity
The points plotted on the graph with the given data indicates many of the pharma
companies shows much ups and down in the industry within the five years spam.
Every company except Orchid Chemicals and Pharmaceuticals and Morepen
Laboratories Ltd shows positive growth in the year 2002 when compare with the year
1998A companies like Zandu Pharmaceuticals Works Ltd, Abbott Laboratories and Torrent
Pharmaceuticals shows a highest negative towards its Total Debt when compare with
its Equity which examines that there is much more liability left unpaid by the
companies in a particular year.
The companies like Pfizer Ltd was much more controllable has the ratio of Total Debts
towards Equity was nulifies after the year 1999
1999 2000 2001 2002
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
25/43
We can also examine that if the ratio is more than 2 it can be considered as company
would be on higher risky side.
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
26/43
Abbott Lab I Ltd
Ajanta Pharma Ltd
Aurobindo Pharma Ltd
Cadila Healthcare Ltd
Cipla Ltd
Dr Reddys Lab Ltd
Duphar Int Ltd
German Remedies Ltd
Glaxo India Ltd
Lupin Lab Ltd
Max India Ltd
Morepen Lab Ltd
Nicholas Piramal I LtdNovartis I Ltd
Orchid Chem & Pharma
Pfizer India
Smithkline Bec Pharma
Sun Pharma Ind Ltd
Torrent Pharma
Zandu Pharma
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
27/43
Debt Coverage Ratio
Company 2002 2001 2000 1999 1998
Abbott Lab I Ltd 24.34 19.58 6.92 2.56 1.95
Ajanta Pharma Ltd 1.72 2.58 3.52 3.65 3.40
Aurobindo Pharma Ltd 3.05 3.29 4.11 3.94 3.01
Cadila Healthcare Ltd 6.30 6.89 3.63 5.84 3.59
Cipla Ltd 82.65 94.19 68.47 37.55 38.24Dr Reddys Lab Ltd 44.38 6.16 6.72 6.57 7.96
Duphar Int Ltd 38.56 46.26 18.41 15.72 6.70
German Remedies Ltd 79.08 58.57 35.45 24.26 12.28
Glaxo India Ltd 14.43 11.16 10.09 13.33 9.72
Lupin Lab Ltd 2.32 1.83 2.06 1.74 2.26
Max India Ltd 2.44 3.64 7.45 17.17 1.37
Morepen Lab Ltd 2.54 2.11 2.95 2.97 3.11
Nicholas Piramal I Ltd 2.97 4.03 3.13 2.64 4.90
Novartis I Ltd 27.78 7.11 82.37 29.43 10.46
Orchid Chem & Pharma 2.28 2.78 2.01 2.44 3.01Pfizer India 347.96 204.28 120.78 19.37 20.10
Smithkline Bec Pharma 719.49 36.91 133.59 103.95 44.95
Sun Pharma Ind Ltd 57.82 21.86 115.19 6.93 6.68
Torrent Pharma 9.85 7.19 3.44 2.17 2.27
Zandu Pharma 6.22 3.92 2.69 3.40 2.80
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
28/43
Definition
Formula
Comments
2.00
102.00
202.00
302.00
402.00
502.00
602.00
702.00
1998
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
29/43
Debt Coverage Rato = Profit Before Interest Payment / Fixed Rate Obligation
Analysing the data we can intimate that the company like Abbott Laboratories India
Ltd, German Remedies Ltd and Dr. Reddy's Laboratories Ltd shows a consistantA company like Smithkline Beecham Pharmaceuticals shows the highest Debt
coverage ratio in the year 2002 , here there has been very high difference if the same
has been compared with the year 2001. The same hike is observed with other
comapnies like Pfizer Ltd, Sun Pharmaceuticals Ltd and Dr. Reddy;s Laboratories Ltd.
spam of five years.
A company named Pfizer Ltd shows a very high debt coverage ratio from the year
1999 2000 2001 2
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
30/43
02
Abbott Lab I Ltd
Ajanta Pharma Ltd
Aurobindo Pharma Ltd
Cadila Healthcare Ltd
Cipla Ltd
Dr Reddys Lab Ltd
Duphar Int Ltd
German Remedies Ltd
Glaxo India Ltd
Lupin Lab Ltd
Max India Ltd
Morepen Lab Ltd
Nicholas Piramal I Ltd
Novartis I Ltd
Orchid Chem & Pharma
Pfizer IndiaSmithkline Bec Pharma
Sun Pharma Ind Ltd
Torrent Pharma
Zandu Pharma
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
31/43
Fixed Asset Turnover Ratio
Company 2002 2001 2000 1999 1998
Abbott Lab I Ltd 3.84 4.24 4.92 5.13 4.13
Ajanta Pharma Ltd 0.96 1.99 5.21 2.45 2.25
Aurobindo Pharma Ltd 4.46 4.78 4.51 5.23 5.35
Cadila Healthcare Ltd 1.69 1.79 2.03 2.70 5.00
Cipla Ltd 3.08 3.46 2.91 2.78 2.71Dr Reddys Lab Ltd 2.62 1.91 1.99 1.96 2.20
Duphar Int Ltd 1.49 1.11 7.12 4.77 3.74
German Remedies Ltd 1.66 1.75 1.85 1.74 1.71
Glaxo India Ltd 3.53 3.63 3.99 3.74 3.48
Lupin Lab Ltd 1.60 2.18 2.31 2.44 2.11
Max India Ltd 1.15 0.90 0.92 0.87 0.90
Morepen Lab Ltd 0.69 0.78 0.84 0.87 1.14
Nicholas Piramal I Ltd 2.74 2.01 1.81 1.88 0.88
Novartis I Ltd 3.04 2.90 4.17 4.21 3.74
Orchid Chem & Pharma 0.69 0.66 0.74 0.94 1.12Pfizer India 3.94 3.90 3.82 3.44 2.39
Smithkline Bec Pharma 4.71 5.63 12.45 10.45 8.47
Sun Pharma Ind Ltd 2.75 2.54 2.38 2.32 1.93
Torrent Pharma 1.73 1.74 2.15 1.67 2.43
Zandu Pharma 1.57 1.38 1.65 2.14 2.86
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
32/43
Definition
Formula
Comments
-
2.00
4.00
6.00
8.00
10.00
12.00
14.00
1998
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
33/43
Fixed Asset Turnover ratio provides how much retun on Investment is achived during
a particular period. Through this ratio we can even compare the profit margin of
different companies within the same Industry.
Fixed Asset Turnover Ratio = Sales Revenue / Fixed Assets
It has been observed that many of the above pharma companies are stable under
above data of Fixed Asset Turnover Ratio
However, the companies like Nicholas Priramal India Ltd,Sun Pharmaceuticals India
Ltd shows a better turnover ratio as compared to other Pharmaceuticals companiesOn the other hand the companies like Novartis India Ltd, Max India Ltd , German
Remedies Ltd , Cipla Ltd , Dr. Reddy's Laboratories Ltd and Abbott laboratories India
Ltd shows a stable turnover ratio under the spam of five years
The companies like Ajanta Phamarceuticals Ltd, Cadila Healthcare Ltd , Duphar
Interfan Ltd , Smithkline Beecham Pharmaceuticals Ltd and Zandu Pharmaceuticals
Ltd shows a very low turnover ratio when compared with the years between 1998 to
1999 2000 2001 2002
Abbott Lab I Ltd
Ajanta Pharma Ltd
Aurobindo Pharma Ltd
Cadila Healthcare Ltd
Cipla Ltd
Dr Reddys Lab Ltd
Duphar Int Ltd
German Remedies Ltd
Glaxo India Ltd
Lupin Lab Ltd
Max India Ltd
Morepen Lab Ltd
Nicholas Piramal I Ltd
Novartis I Ltd
Orchid Chem & Pharma
Pfizer India
Smithkline Bec Pharma
Sun Pharma Ind Ltd
Torrent Pharma
Zandu Pharma
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
34/43
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
35/43
Exports as per cent of Total Sales
Company 2002 2001 2000 1999 1998
Abbott Lab I Ltd 7.03 5.35 3.39 2.31 1.81
Ajanta Pharma Ltd 52.17 40.00 36.28 35.78 54.17
Aurobindo Pharma Ltd 49.74 57.60 53.07 42.84 35.17
Cadila Healthcare Ltd 16.07 12.61 8.56 9.00 9.71
Cipla Ltd 38.53 27.08 20.36 20.03 15.20Dr Reddys Lab Ltd 65.30 46.84 30.05 31.47 37.41
Duphar Int Ltd 31.23 32.22 6.76 6.17 7.19
German Remedies Ltd - - 1.12 1.00 1.09
Glaxo India Ltd 6.77 8.42 8.52 8.33 6.54
Lupin Lab Ltd 24.32 30.73 35.72 33.38 31.08
Max India Ltd 26.69 9.64 14.22 14.16 13.69
Morepen Lab Ltd 12.49 9.92 9.71 10.99 13.83
Nicholas Piramal I Ltd 1.15 0.66 0.97 1.49 6.66
Novartis I Ltd 1.22 3.40 7.28 7.29 12.35
Orchid Chem & Pharma 86.19 88.29 84.34 89.99 90.22Pfizer India 4.80 5.14 6.42 5.94 5.01
Smithkline Bec Pharma 8.45 6.80 2.94 4.02 6.54
Sun Pharma Ind Ltd 19.22 20.23 12.53 18.55 14.57
Torrent Pharma 7.88 7.81 28.04 9.55 31.90
Zandu Pharma 0.72 0.46 0.38 0.83 0.77
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
36/43
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
37/43
Definition
Formula
Comments
-
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
90.00
100.00
1998
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
38/43
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
39/43
Export Turnover Ratio towards Total Sales provides the how company spreads its
market share. It can also provide how company generates its Revenue towards its
sales in foreign countries
Export Turnover Ratio = Export Sales / Total Revenue (Sales)
From the data, It has been observed that the only Company named Orchid Chemicalsand Paharmaceuticals shows the highest export turnover for all the spam of five
years, But there is consitence ratio main towrds that particular period. However apart
from Orchid Chemicals and Pharmaceuticals Ltd other companies also show a stable
ratio like Sun Pharmaceuticals India Ltd , Ajanta Pharmaceuticals Ltd, Aurobindo
Pharma Ltd, Cadila Healthcare Ltd and even Zandu Pharmacceuticals has overcome
with a consisitant growth for the last three years
1999 2000 2001 2002
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
40/43
On the Other side there has been significant growth in Export Turnover Ratio for the
companies like Abbott Laboratories India Ltd though it has been on lower side with
other pharmaceuticals companies but has shown a growth of approxiemetly of 288%
when comapred from the year 1998 to 2002.
Apart from Abbott Laboratories India Ltd a company name Cipla Ltd has also shown a
significant growth of around 153% over the spam of five years
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
41/43
Abbott Lab I Ltd
Ajanta Pharma Ltd
Aurobindo Pharma Ltd
Cadila Healthcare Ltd
Cipla Ltd
Dr Reddys Lab Ltd
Duphar Int Ltd
German Remedies Ltd
Glaxo India Ltd
Lupin Lab Ltd
Max India Ltd
Morepen Lab Ltd
Nicholas Piramal I Ltd
Novartis I Ltd
Orchid Chem & Pharma
Pfizer India
Smithkline Bec Pharma
Sun Pharma Ind Ltd
Torrent Pharma
Zandu Pharma
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
42/43
Comments
-
8/2/2019 Investment and Protfolio Analysis - Assignment of Pharma Companies R B036
43/43
From above all the data provided for all twenty Pharmaceuticlas
companies and when compared with all the ratios provided and as per
graphical analysis it has been observed that Dr. Reddy's Laboratories
Ltdperfomance in all the ratio is well maintained and it has shown aApart from Dr. Reddy's laboaratories Ltd, the other pharma companies
like Sun Phamaceuticals Industries Ltd and Cipla Ltd have alsoWe can also conclude that the Zandu Pharmaceuticals Works Ltd ,
Max India Ltd and Novartis India Ltd has shown a consistent return